Genentech to Discontinue Fuzeon® (Enfuvirtide) Amid Evolving HIV Treatment Landscape

Richard Waithe
Genentech to Discontinue Fuzeon® (Enfuvirtide) Amid Evolving HIV Treatment Landscape
Drug Discontinuations & WithdrawalsInfectious DiseaseReimbursement

Related Articles

FDA to Crackdown on Non-Approved GLP-1 Drugs
News

FDA to Crackdown on Non-Approved GLP-1 Drugs

FDA Removes REMS Program for Clozapine Despite Neutropenia Risk
News

FDA Removes REMS Program for Clozapine Despite Neutropenia Risk

Lyra Therapeutics Suspends Development of LYR-210 for Chronic Rhinosinusitis Despite Positive Trial Results
News

Lyra Therapeutics Suspends Development of LYR-210 for Chronic Rhinosinusitis Despite Positive Trial Results